GUETH ANTON 4
4 · ANTARES PHARMA, INC. · Filed May 3, 2021
Insider Transaction Report
Form 4
GUETH ANTON
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-04-29−72,669→ 0 totalExercise: $1.66Exp: 2021-05-16→ Common Stock (72,669 underlying) - Exercise/Conversion
Common Stock
2021-04-29$1.66/sh+72,669$120,631→ 502,125 total
Footnotes (1)
- [F1]The options vested in four equal quarterly installments from the grant date of May 17, 2011. The stock options were due to expire on May 16, 2021.